Publication | Closed Access

A new conditioning regimen involving total marrow irradiation, busulfan and cyclophosphamide followed by autologous PBSCT in patients with advanced multiple myeloma

Hematological MalignancyAdvanced Multiple MyelomaBone Marrow FailureMedicineNew Conditioning RegimenImmunologyHematologyTotal Marrow IrradiationOncologyCell Transplantation